UK markets closed

Arbutus Biopharma Corporation (ABUS)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.0700-0.1300 (-4.06%)
At close: 4:00PM EDT

3.0500 -0.02 (-0.65%)
After hours: 7:29PM EDT

Show:
Income statement
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2020
31/12/2019
31/12/2018
31/12/2017
Total revenue
6,914
6,914
6,011
5,945
10,700
Cost of revenue
47,481
47,481
57,601
57,934
62,676
Gross profit
-40,567
-40,567
-51,590
-51,989
-51,976
Operating expenses
Selling general and administrative
14,724
14,724
17,727
16,002
16,129
Total operating expenses
16,702
16,702
19,755
18,183
18,156
Operating income or loss
-57,269
-57,269
-71,345
-70,172
-70,132
Interest expense
4,011
4,011
2,108
226
261
Total other income/expenses net
-3,206
-3,206
-95,037
6,009
-39,878
Income before tax
-63,745
-63,745
-166,379
-61,342
-108,733
Income tax expense
0
0
-12,656
-4,282
-24,320
Income from continuing operations
-63,745
-63,745
-153,723
-57,060
-84,413
Net income
-63,745
-63,745
-153,723
-57,060
-84,413
Net income available to common shareholders
-75,868
-75,868
-164,872
-67,151
-85,324
Basic EPS
-
-
-2.89
-1.21
-1.56
Diluted EPS
-
-
-2.89
-1.21
-1.56
Basic average shares
-
-
57,093
55,304
54,103
Diluted average shares
-
-
57,093
55,304
54,103
EBITDA
-
-57,756
-162,243
-58,935
-106,445